Jean Dallongeville

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Ian D. Graham, Dan Atar, K. Borch‐Johnsen et al. · European Heart Journal · 2007 · 3.8K citations · Full text

Medicine, Cardiology, Clinical Cardiology +14

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Ian Graham, Dan Atar, Knut Borch‐Johnsen et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2007 · 1.7K citations

Medicine, Cardiology, Internal Medicine +12

EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

Daniel De Backer, K. Borch‐Johnsen, Carlos Brotons et al. · Rational Pharmacotherapy in Cardiology · 2005 · 1.3K citations · Full text

Medicine, Cardiology, Preventive Medicine +16

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

Bart Staels, Ngoc Vu‐Dac, V. A. Kosykh et al. · Journal of Clinical Investigation · 1995 · 409 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Ngoc Vu‐Dac, Kristina Schoonjans, V. P. Kosykh et al. · Journal of Clinical Investigation · 1995 · 397 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17